AEVIS VICTORIA SA / Key word(s): Acquisition 12-Dec-2024 / 12:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Fribourg, 12 December 2024 AEVIS VICTORIA SA (AEVS.SW) – AEVIS VICTORIA announces the acquisition of Spital Zofingen by Swiss Medical Network and a strategic partnership with Kantonsspital Aarau AEVIS VICTORIA SA (AEVIS) announces the acquisition of Spital Zofingen, a subsidiary of Kantonsspital Aarau AG (KSA), by Swiss Medical Network Holding SA (SMN), marking an important milestone in its strategy for growth and the development of integrated healthcare in Switzerland. This acquisition, with payment made in SMN shares, paves the way for a strategic partnership between SMN and KSA. KSA becomes a strategic shareholder in SMN, holding 3.57% of the capital, thereby establishing a sustainable collaboration between the two institutions. This transaction confirms the valuation of SMN, consistent with the valuation applied during the capital increase with Visana Beteiligungen. As a result of this operation, AEVIS’s consolidated equity will increase by CHF 50 million. Additionally, the integration of Spital Zofingen is expected to boost the group’s consolidated revenues by approximately CHF 100 million in 2025, underscoring the significant financial impact of this acquisition. The acquisition of Spital Zofingen will generate substantial synergies, particularly in procurement, training, and resource allocation. These efficiencies are expected to positively impact the group’s consolidated results from the 2025 fiscal year onward, enhancing operational performance and the quality of care. This acquisition aligns also with the development of integrated healthcare, a strategic pillar for SMN and KSA. Together, the two partners aim to establish a new collaborative model to benefit patients and enhance the efficiency of the Swiss healthcare system. Antoine Hubert, Delegate of the Board of AEVIS, said: “This acquisition fits perfectly into our strategy of broadening Swiss Medical Network’s shareholder base by bringing in top-tier strategic partners. By partnering with Kantonsspital Aarau, we strengthen our commitment to integrated healthcare and consolidate our position in the Swiss healthcare market.” Conference call today at 3 p.m. For further information: AEVIS VICTORIA SA – Investing for a better life End of Inside Information |
Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
Dive Brief: Vivos Therapeutics has received 510(k) clearance for the use of its oral devices in adults with severe obstructive sleep apnea (OSA). The Food